Hikal Limited

Pharmaceuticals

HIKAL-EQ: NSEBSE: 9668

Hikal Limited (HIKAL-EQ) live share price today at NSE / BSE

INR 225.29

+0.91 (0.41%)1 Day

Thu, 17 Sept 2026, 03:12 PM

About HIKAL-EQ

Hikal Ltd is an integrated life sciences company specializing in research, development, and manufacturing solutions for the pharmaceuticals, crop protection, and specialty chemicals sectors. Founded in 1988 and headquartered in Mumbai, India, the company provides contract research and manufacturing services (CRAMS) to global innovators in pharmaceutical and agrochemical industries. Hikal owns and operates multiple manufacturing facilities and R&D centers across India, adhering to international regulatory standards, including those set by USFDA, EMEA, and PMDA.

52 Week Range

HighINR 282.70

LowINR 146.25

Current Signal

red

Open

INR 222.23

High

INR 231.35

Low

INR 219.95

Prev. Close

INR 224.38

Volume

6,47,006

Avg. Volume (7D)

61,81,046

Avg. Volume (10D)

69,46,199

Latest Signal

Sell

Sell Price

INR 227.2

Close Price

INR 224.95

Change

10.29%

Signal Date

2026-09-11

Hold

Pattern

Bullish

Company Snapshot

CIN	L24200MH1988PTC048028
Industry	Pharmaceuticals
Market Lot	1
Impact Cost	0.1%
Listing Date	09 Jan 1995
BC Record Date	RD 02/09/2025
Registered Address	717/718, Maker Chamber V, 7th Floor, Nariman Point
Auditor	S R B C & CO LLP

Registrar

Name

MUFG Intime India Pvt. Ltd

Telephone

8108116767

Website

www.in.mpms.mufg.com

Shareholding Pattern

Quarterly filing · 30 Jun 2026

Promoter & Promoter Group68.85%

Non-Institutions24.56%

Board of Directors

Mr.Amit KalyaniNon-Executive - Non Independent Director

Mr.Berjis Minoo DesaiNon-Executive - Independent Director

Mr.Jai HiremathExecutive Director-Chairperson related to Promoter

Mr.Kuldeep JainChief Financial Officer

Mr.Rajasekhar ReddyWhole-Time Company Secretary & Compliance Officer

Mr.Ramachandra Kaundinya VinnakotaNon-Executive - Independent Director

Mr.Ravi Brijmohan KapoorNon-Executive - Independent Director

Mr.Sameer HiremathExecutive Director-MD

Mr.Sarangan SureshExecutive Director

Mr.Shrikrishna Kiran AdivarekarNon-Executive - Independent Director

Mrs.Ranjana Shivanand SalgaocarNon-Executive - Independent Director

Mrs.Sugandha HiremathNon-Executive - Non Independent Director

Ms.Shivani Bhasin SachdevaNon-Executive - Independent Director

Today Share Price

Hikal Limited

Particulars	Details
Opening Price	INR 222.23
Previous Closing Price	INR 224.38
Volume of Hikal Limited	6,47,006
Value of Share	—

Today NSE Share Price

Hikal Limited

Particulars	Details
Live Share Price NSE India	INR 225.29
Previous Closing Price	INR 224.38
Open Price	INR 222.23
High	INR 231.35
Low	INR 219.95

Today BSE Share Price

Hikal Limited

Particulars	Details
Live Share Price BSE India	INR 225.29
Previous Closing Price	INR 224.38
Open Price	INR 222.23
High	INR 231.35
Low	INR 219.95

Hikal Limited

The company’s pharmaceutical division produces active pharmaceutical ingredients (APIs), intermediates, and custom synthesis products, serving leading global pharma companies. The crop protection division engages in the development and manufacturing of active ingredients, intermediates, and contract manufacturing services for leading agrochemical multinationals, supporting market access in regulated and emerging geographies.

Frequently Asked Questions – StockYaari Stock Page

Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.

Final Thoughts

Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.